Ray Amrit
SEC CIK 1924797 · EDGAR
Most active insiders at FTRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Thakral Anshul | CEO, Dir | — | $3.94M |
| 2 | Morais Mark A. | COO | — | $370.7K |
| 3 | SANDERS MACHELLE | Dir | — | $174.7K |
| 4 | Mcconnell Jill G. | CFO | — | $150.1K |
| 5 | Parks Robert | CAO | — | $44.4K |
| 6 | Russell Carrie Elizabeth | Interim CAO | — | $4,145 |
| 7 | Ray Amrit | Dir | — | — |
| 8 | Smith David Ross | Dir | — | — |
| 9 | Russell Erin L | Dir | — | — |
| 10 | Pesicka Edward A | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 16:09 | 2026-06-10 | FTRE | Fortrea Holdings Inc. | Ray Amrit | Dir | M - OptEx | $0.00 | +38.8K | 52.5K | +285% | $0 |
| D | 2026-05-18 18:39 | 2026-05-14 | RARE | Ultragenyx Pharmaceutical Inc. | Ray Amrit | Dir | A - Grant | $0.00 | +7,751 | 31.1K | +33% | $0 |
| D | 2025-05-19 | 2025-05-15 | RARE | Ultragenyx Pharmaceutical Inc. | Ray Amrit | Dir | A - Grant | $0.00 | +5,740 | 23.4K | +33% | $0 |
| D | 2025-05-16 | 2025-05-14 | FTRE | Fortrea Holdings Inc. | Ray Amrit | Dir | M - OptEx | $0.00 | +7,282 | 13.6K | +115% | $0 |
| D | 2024-07-19 | 2024-07-18 | FTRE | Fortrea Holdings Inc. | Ray Amrit | Dir | M - OptEx | $0.00 | +6,354 | 6,354 | New | $0 |
| D | 2024-06-20 | 2024-06-18 | RARE | Ultragenyx Pharmaceutical Inc. | Ray Amrit | Dir | A - Grant | $0.00 | +5,345 | 17.6K | +44% | $0 |
| D | 2023-06-09 | 2023-06-07 | RARE | Ultragenyx Pharmaceutical Inc. | Ray Amrit | Dir | A - Grant | $0.00 | +3,860 | 12.3K | +46% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | Ultragenyx Pharmaceutical Inc. | Ray Amrit | Dir | A - Grant | $0.00 | +3,300 | 8,420 | +64% | $0 |
| D | 2022-04-22 | 2022-04-19 | RARE | Ultragenyx Pharmaceutical Inc. | Ray Amrit | Dir | A - Grant | $0.00 | +5,120 | 5,120 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations